Samay’s patented device uses acoustic resonance to measure air trapping, an early predictor of COPD exacerbations and mortality. Our chest-wearable patch emits low-frequency sound, detecting acoustic resonance signals from the lungs. Smartphone-based software analyzes them and alerts clinicians when to intervene, reducing hospitalizations, the main driver of U.S. COPD expenses.
